Cargando…

Malignant Pleural Effusions: Updates in Diagnosis and Management

Malignant pleural effusions remain a significant clinical problem resulting in greater than 125,000 hospitalizations per year and leading to over 5 billion dollars in healthcare utilization costs. Not only are health care expenditures related to malignant pleural effusion significant, but malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Stephen M., Carmichael, Jacob Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861375/
https://www.ncbi.nlm.nih.gov/pubmed/36676064
http://dx.doi.org/10.3390/life13010115
_version_ 1784874825758539776
author Hughes, Stephen M.
Carmichael, Jacob Jonas
author_facet Hughes, Stephen M.
Carmichael, Jacob Jonas
author_sort Hughes, Stephen M.
collection PubMed
description Malignant pleural effusions remain a significant clinical problem resulting in greater than 125,000 hospitalizations per year and leading to over 5 billion dollars in healthcare utilization costs. Not only are health care expenditures related to malignant pleural effusion significant, but malignant pleural effusions also often result in significant patient discomfort and distress, largely at the end of life. Advances in management over the past several years have provided patients with greater autonomy as they are able to provide self-aid at home either alone or with family assistance. Additionally, practice changes have allowed for fewer interventions allowing patients to spend more time out of the clinic or inpatient wards.
format Online
Article
Text
id pubmed-9861375
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98613752023-01-22 Malignant Pleural Effusions: Updates in Diagnosis and Management Hughes, Stephen M. Carmichael, Jacob Jonas Life (Basel) Review Malignant pleural effusions remain a significant clinical problem resulting in greater than 125,000 hospitalizations per year and leading to over 5 billion dollars in healthcare utilization costs. Not only are health care expenditures related to malignant pleural effusion significant, but malignant pleural effusions also often result in significant patient discomfort and distress, largely at the end of life. Advances in management over the past several years have provided patients with greater autonomy as they are able to provide self-aid at home either alone or with family assistance. Additionally, practice changes have allowed for fewer interventions allowing patients to spend more time out of the clinic or inpatient wards. MDPI 2022-12-31 /pmc/articles/PMC9861375/ /pubmed/36676064 http://dx.doi.org/10.3390/life13010115 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hughes, Stephen M.
Carmichael, Jacob Jonas
Malignant Pleural Effusions: Updates in Diagnosis and Management
title Malignant Pleural Effusions: Updates in Diagnosis and Management
title_full Malignant Pleural Effusions: Updates in Diagnosis and Management
title_fullStr Malignant Pleural Effusions: Updates in Diagnosis and Management
title_full_unstemmed Malignant Pleural Effusions: Updates in Diagnosis and Management
title_short Malignant Pleural Effusions: Updates in Diagnosis and Management
title_sort malignant pleural effusions: updates in diagnosis and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861375/
https://www.ncbi.nlm.nih.gov/pubmed/36676064
http://dx.doi.org/10.3390/life13010115
work_keys_str_mv AT hughesstephenm malignantpleuraleffusionsupdatesindiagnosisandmanagement
AT carmichaeljacobjonas malignantpleuraleffusionsupdatesindiagnosisandmanagement